Reaction
Mental Fatigue reporting signals
As of the last recalculation, Mental Fatigue appears in 1,458 FAERS reports alongside 25 co-occurring drug terms. The strongest observed disproportionality signal is CARIPRAZINE (PRR 10.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cariprazine | 7 | 10.8 | 10.8 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 9 | 10.4 | 10.4 |
| Goserelin | 9 | 9.6 | 9.6 |
| Cladribine | 6 | 8.9 | 8.9 |
| Ofatumumab | 20 | 8.7 | 8.7 |
| Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate | 21 | 8.6 | 8.6 |
| Asfotase Alfa | 6 | 8.6 | 8.6 |
| Loperamide Hydrochloride Oral | 6 | 8.4 | 8.4 |
| Naltrexone Hydrochloride And Bupropion Hydrochloride | 5 | 8.4 | 8.4 |
| Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate | 24 | 8.4 | 8.4 |
| Docetaxel Anhydrous | 32 | 6.9 | 6.9 |
| Docetaxel | 31 | 6.7 | 6.7 |
| Ravulizumab | 6 | 6.4 | 6.4 |
| Relugolix | 10 | 6.1 | 6.1 |
| Fam-Trastuzumab Deruxtecan-Nxki | 4 | 5.7 | 5.7 |
| Ocrelizumab | 24 | 5.6 | 5.6 |
| Lurasidone Hydrochloride | 8 | 5.5 | 5.5 |
| Brexpiprazole | 6 | 5.2 | 5.2 |
| Abemaciclib | 7 | 5.0 | 5.0 |
| Apalutamide | 4 | 4.9 | 4.9 |
| Fingolimod Hcl | 29 | 4.9 | 4.9 |
| Minoxidil Foam 5% (Womens) | 7 | 3.0 | 3.0 |
| Galcanezumab-Gnlm | 5 | 2.3 | 2.3 |
| Minoxidil | 7 | 2.2 | 2.2 |
| Droxidopa | 3 | 2.0 | 2.0 |